CV Sciences Inc (CVSI)

[Art Vandeley]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
August 18, 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
CV Sciences, Inc.
File No. 5-87082 -CF#33491
_____________________
Michael Joseph Mona, Jr. submitted an application under Rule 24b-2 requesting
confidential treatment for information he excluded from the Exhibit to a Schedule 13D/A
filed on February 12, 2016 relating to his beneficial ownership of common shares of CV
Sciences, Inc.
Based on representations by Michael Joseph Mona, Jr. that this information
qualifies as confidential commercial or financial information and information contained
in personnel, medical or similar files that if disclosed would constitute an unwarranted
invasion of privacy under the Freedom of Information Act, 5 U.S.C. 552(b)(4) and (6),
the Division of Corporation Finance has determined not to publicly disclose it.
Accordingly, excluded information from the following exhibit will not be released to the
public for the time period specified:
Exhibit 4 through July 23, 2025
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Fields
Secretary